On the public citation graph
Targeting Sodium Taurocholate Co-Transporting Polypeptide (NTCP) in Cholestatic Liver Disease: Therapeutic Potential and Clinical Implications
0 signed · 97 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/bdd.1861openalex-snapshot
Quantitative assessment of the contribution of sodium‐dependent taurocholate co‐transporting polypeptide (NTCP) to the hepatic uptake of rosuvastatin, pitavastatin and fluvastatin
inferredcites →https://doi.org/10.1002/hep.26225openalex-snapshot
Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1002/hep.26454openalex-snapshot
Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in utah children: Epidemiology and natural history
inferredcites →https://doi.org/10.1002/hep.27240openalex-snapshot
Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: Conjugated hypercholanemia without a clear clinical phenotype
inferredcites →https://doi.org/10.1002/hep.28991openalex-snapshot
New therapeutic concepts in bile acid transport and signaling for management of cholestasis
inferredcites →https://doi.org/10.1002/hep.29251openalex-snapshot
Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice
inferredcites →https://doi.org/10.1002/hep.29888openalex-snapshot
Na+‐taurocholate cotransporting polypeptide inhibition has hepatoprotective effects in cholestasis in mice
inferredcites →https://doi.org/10.1002/hep.30792openalex-snapshot
Blocking Sodium‐Taurocholate Cotransporting Polypeptide Stimulates Biliary Cholesterol and Phospholipid Secretion in Mice
inferredcites →https://doi.org/10.1002/hep.31651openalex-snapshot
Targeting the Four Pillars of Enterohepatic Bile Salt Cycling; Lessons From Genetics and Pharmacology
inferredcites →https://doi.org/10.1002/lt.26514openalex-snapshot
Financial burden in adults with chronic liver disease: A scoping review
inferredcites →https://doi.org/10.1007/s00535-020-01681-zopenalex-snapshot
Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities
inferredcites →https://doi.org/10.1007/s40265-021-01545-7openalex-snapshot
Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents
inferredcites →https://doi.org/10.1016/j.apsb.2016.07.003openalex-snapshot
Crosstalk of HNF4α with extracellular and intracellular signaling pathways in the regulation of hepatic metabolism of drugs and lipids
inferredcites →https://doi.org/10.1016/j.bbadis.2025.167972openalex-snapshot
The role of bile salts in itch receptor activation
inferredcites →https://doi.org/10.1016/j.celrep.2014.10.041openalex-snapshot
The RNA-Editing Enzyme ADAR1 Controls Innate Immune Responses to RNA
inferredcites →https://doi.org/10.1016/j.cld.2022.03.001openalex-snapshot
Biliary Atresia in Children
inferredcites →https://doi.org/10.1016/j.cld.2022.06.009openalex-snapshot
Evaluation and Management of Pruritus in Primary Biliary Cholangitis
inferredcites →https://doi.org/10.1016/j.clinre.2018.07.010openalex-snapshot
Systematic review of progressive familial intrahepatic cholestasis
inferredcites →https://doi.org/10.1016/j.clinre.2021.101824openalex-snapshot
Sodium taurocholate co-transporting polypeptide deficiency
inferredcites →https://doi.org/10.1016/j.gastha.2023.05.004openalex-snapshot
Risk of Cancer and Subsequent Mortality in Primary Biliary Cholangitis: A Population-based Cohort Study of 3052 Patients
inferredcites →https://doi.org/10.1016/j.ijid.2019.01.038openalex-snapshot
NTCP S267F variant associates with decreased susceptibility to HBV and HDV infection and decelerated progression of related liver diseases
inferredcites →https://doi.org/10.1016/j.immuni.2015.11.001openalex-snapshot
Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development
inferredcites →https://doi.org/10.1016/j.jcmgh.2020.09.001openalex-snapshot
NTCP Deficiency Causes Gallbladder Abnormalities in Mice and Human Beings
inferredcites →https://doi.org/10.1016/j.jhep.2011.10.025openalex-snapshot
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review
inferredcites →https://doi.org/10.1016/j.jhep.2013.01.040openalex-snapshot
Improving outcomes of biliary atresia: French national series 1986–2009
inferredcites →https://doi.org/10.1016/j.jhep.2017.03.022openalex-snapshot
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
inferredcites →https://doi.org/10.1016/j.jhep.2018.08.020openalex-snapshot
Primary biliary cholangitis: A tale of epigenetically-induced secretory failure?
inferredcites →https://doi.org/10.1016/j.jhep.2019.04.001openalex-snapshot
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis
inferredcites →https://doi.org/10.1016/j.jhep.2022.05.011openalex-snapshot
EASL Clinical Practice Guidelines on sclerosing cholangitis
inferredcites →https://doi.org/10.1016/j.jhep.2024.05.001openalex-snapshot
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial
inferredcites →https://doi.org/10.1016/j.jhep.2025.04.025openalex-snapshot
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial
inferredcites →https://doi.org/10.1016/j.jhepr.2024.101168openalex-snapshot
Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis
inferredcites →https://doi.org/10.1016/j.jlr.2024.100594openalex-snapshot
Inhibition of hepatic bile salt uptake by Bulevirtide reduces atherosclerosis in Oatp1a1 Ldlr mice
inferredcites →https://doi.org/10.1016/j.jpedsurg.2011.04.013openalex-snapshot
Biliary atresia in England and Wales: results of centralization and new benchmark
inferredcites →https://doi.org/10.1016/j.liver.2023.100186openalex-snapshot
Outcomes of patients with primary sclerosing cholangitis after liver transplantation in a predominantly living donor liver transplant center
inferredcites →https://doi.org/10.1016/j.mayocp.2020.01.015openalex-snapshot
Cholestatic Liver Diseases
inferredcites →https://doi.org/10.1016/j.mce.2009.08.003openalex-snapshot
Study of the transport of thyroid hormone by transporters of the SLC10 family
inferredcites →https://doi.org/10.1016/j.steroids.2014.07.001openalex-snapshot
Steroid sulfatase mediated growth Sof human MG-63 pre-osteoblastic cells
inferredcites →https://doi.org/10.1016/s0140-6736(24)01303-5openalex-snapshot
Primary biliary cholangitis
inferredcites →https://doi.org/10.1016/s0168-8278(23)01056-5openalex-snapshot
Burden, impact and variability of pruritus in primary sclerosing cholangitis (PSC) over time: a prospective observational study
inferredcites →https://doi.org/10.1021/acs.accounts.3c00433openalex-snapshot
Adenosine Deaminase Acting on RNA (ADAR) Enzymes: A Journey from Weird to Wondrous
inferredcites →https://doi.org/10.1038/ejhg.2011.181openalex-snapshot
Alagille syndrome: pathogenesis, diagnosis and management
inferredcites →https://doi.org/10.1038/s41422-022-00680-4openalex-snapshot
Structure of human NTCP reveals the basis of recognition and sodium-driven transport of bile salts into the liver
inferredcites →https://doi.org/10.1038/s41575-019-0132-zopenalex-snapshot
Neonatal cholestasis: emerging molecular diagnostics and potential novel therapeutics
inferredcites →https://doi.org/10.1038/s41586-022-04723-zopenalex-snapshot
Structural basis of sodium-dependent bile salt uptake into the liver
inferredcites →https://doi.org/10.1038/s41586-022-04845-4openalex-snapshot
Structure of the bile acid transporter and HBV receptor NTCP
inferredcites →https://doi.org/10.1038/s41586-022-04857-0openalex-snapshot
Structural insights into the HBV receptor and bile acid transporter NTCP
inferredcites →https://doi.org/10.1053/gast.1996.v110.pm8536857openalex-snapshot
Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis
inferredcites →https://doi.org/10.1053/j.gastro.2008.01.038openalex-snapshot
Severe Bile Salt Export Pump Deficiency: 82 Different ABCB11 Mutations in 109 Families
inferredcites →https://doi.org/10.1056/nejmoa2312100openalex-snapshot
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis
inferredcites →https://doi.org/10.1074/jbc.m305782200openalex-snapshot
Ethnicity-dependent Polymorphism in Na+-taurocholate Cotransporting Polypeptide (SLC10A1) Reveals a Domain Critical for Bile Acid Substrate Recognition
inferredcites →https://doi.org/10.1074/jbc.ra118.007179openalex-snapshot
Increased sulfation of bile acids in mice and human subjects with sodium taurocholate cotransporting polypeptide deficiency
inferredcites →https://doi.org/10.1080/00498250802040584openalex-snapshot
Bile acid transporters in health and disease
inferredcites →https://doi.org/10.1080/14728214.2024.2336986openalex-snapshot
Emerging drugs for the treatment of progressive familial intrahepatic cholestasis: a focus on phase II and III trials
inferredcites →https://doi.org/10.1093/infdis/jiy355openalex-snapshot
The Loss-of-Function S267F Variant in HBV Receptor NTCP Reduces Human Risk for HBV Infection and Disease Progression
inferredcites →https://doi.org/10.1097/hep.0000000000001172openalex-snapshot
Medical treatment of primary sclerosing cholangitis: What have we learned and where are we going?
inferredcites →https://doi.org/10.1097/hep.0000000000001198openalex-snapshot
Obeticholic acid as second-line therapy for primary biliary cholangitis: Does target trial emulation solve the issue?
inferredcites →https://doi.org/10.1097/hep.0000000000001341openalex-snapshot
Epidemiological and economical burden of cholestatic liver disease
inferredcites →https://doi.org/10.1097/hep.0000000000001438openalex-snapshot
Benefits and challenges to therapeutic targeting of bile acid circulation in cholestatic liver disease
inferredcites →https://doi.org/10.1097/lvt.0000000000000348openalex-snapshot
Financial burden following adult liver transplantation is common and associated with adverse recipient outcomes
inferredcites →https://doi.org/10.1097/lvt.0000000000000523openalex-snapshot
Long-term (15 y) complications and outcomes after liver transplantation for primary sclerosing cholangitis: Impact of donor and recipient factors
inferredcites →https://doi.org/10.1097/md.0000000000017305openalex-snapshot
Clinical and histopathologic features of sodium taurocholate cotransporting polypeptide deficiency in pediatric patients
inferredcites →https://doi.org/10.1097/mpg.0000000000001334openalex-snapshot
Guideline for the Evaluation of Cholestatic Jaundice in Infants
inferredcites →https://doi.org/10.1111/apt.70598openalex-snapshot
Review Article: Targeting Peroxisome Proliferator‐Activated Receptors in Primary Biliary Cholangitis
inferredcites →https://doi.org/10.1111/liv.15031openalex-snapshot
Clinical characterization of NTCP deficiency in paediatric patients : A case‐control study based on SLC10A1 genotyping analysis
inferredcites →https://doi.org/10.1111/liv.15471openalex-snapshot
Disease burden in primary sclerosing cholangitis in the Netherlands: A long‐term follow‐up study
inferredcites →https://doi.org/10.1111/liv.70557openalex-snapshot
Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study
inferredcites →https://doi.org/10.1136/bmjgast-2021-000778openalex-snapshot
Post-transplant biliary complications: advances in pathophysiology, diagnosis, and treatment
inferredcites →https://doi.org/10.1136/bmjgast-2025-001809openalex-snapshot
Pruritus and health-related quality of life in chronic liver disease: a longitudinal, survey-based cohort study
inferredcites →https://doi.org/10.1136/gutjnl-2015-310686openalex-snapshot
The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B
inferredcites →https://doi.org/10.1136/gutjnl-2020-323345openalex-snapshot
Sodium + /taurocholate cotransporting polypeptide as target therapy for liver fibrosis
inferredcites →https://doi.org/10.1136/gutjnl-2021-324305openalex-snapshot
Novel therapeutic targets for cholestatic and fatty liver disease
inferredcites →https://doi.org/10.1152/ajpgi.00031.2015openalex-snapshot
TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration
inferredcites →https://doi.org/10.1152/ajpgi.00417.2002openalex-snapshot
III. Bile acids and nuclear receptors
inferredcites →https://doi.org/10.1159/000450984openalex-snapshot
Extended Abstract: Deficiency of Sodium Taurocholate Cotransporting Polypeptide (SLC10A1): A New Inborn Error of Metabolism with an Attenuated Phenotype
inferredcites →https://doi.org/10.1177/24725552211017500openalex-snapshot
Functional and Pharmacological Comparison of Human and Mouse Na+/Taurocholate Cotransporting Polypeptide (NTCP)
inferredcites →https://doi.org/10.1186/s12876-025-03821-2openalex-snapshot
Efficacy and safety of PPAR agonists in primary biliary cholangitis: a systematic review and meta-analysis of Randomized Controlled Trials
inferredcites →https://doi.org/10.1186/s12929-023-00981-9openalex-snapshot
Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges
inferredcites →https://doi.org/10.1186/s13023-025-03599-2openalex-snapshot
Genotypes and different clinical variants between children and adults in progressive familial intrahepatic cholestasis: a state-of-the-art review
inferredcites →https://doi.org/10.1186/s13578-023-01035-1openalex-snapshot
Bile acid-mediated signaling in cholestatic liver diseases
inferredcites →https://doi.org/10.1210/er.2015-1036openalex-snapshot
The Regulation of Steroid Action by Sulfation and Desulfation
inferredcites →https://doi.org/10.1210/er.2018-00134openalex-snapshot
Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives
inferredcites →https://doi.org/10.12998/wjcc.v9.i36.11487openalex-snapshot
De novo mutation loci and clinical analysis in a child with sodium taurocholate cotransport polypeptide deficiency: A case report
inferredcites →https://doi.org/10.18632/oncotarget.22211openalex-snapshot
Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinoma
inferredcites →https://doi.org/10.18632/oncotarget.22503openalex-snapshot
Sodium taurocholate cotransporting polypeptide (NTCP) deficiency: Identification of a novel SLC10A1 mutation in two unrelated infants presenting with neonatal indirect hyperbilirubinemia and remarkable hypercholanemia
inferredcites →https://doi.org/10.21037/tp-20-360openalex-snapshot
Clinical features of sodium-taurocholate cotransporting polypeptide deficiency in pediatric patients: case series and literature review
inferredcites →https://doi.org/10.3109/00498254.2011.555567openalex-snapshot
Genetic polymorphisms in Na+-taurocholate co-transporting polypeptide (NTCP) and ileal apical sodium-dependent bile acid transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populations
inferredcites →https://doi.org/10.32074/1591-951x-245openalex-snapshot
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
inferredcites →https://doi.org/10.3389/fcimb.2019.00018openalex-snapshot
Diverse Effects of the NTCP p.Ser267Phe Variant on Disease Progression During Chronic HBV Infection and on HBV preS1 Variability
inferredcites →https://doi.org/10.3389/fphys.2026.1747341openalex-snapshot
The role of bile acid-activated receptor TGR5 in inflammation and liver diseases
inferredcites →https://doi.org/10.3390/ijms23137468openalex-snapshot
Hepatic Expression of the Na+-Taurocholate Cotransporting Polypeptide Is Independent from Genetic Variation
inferredcites →https://doi.org/10.3390/jcm11040999openalex-snapshot
Biliary Atresia in 2021: Epidemiology, Screening and Public Policy
inferredcites →https://doi.org/10.3390/livers1040019openalex-snapshot
Na+-Taurocholate Co-Transporting Polypeptide (NTCP) in Livers, Function, Expression Regulation, and Potential in Hepatitis B Treatment
inferredcites →https://doi.org/10.3748/wjg.v22.i31.6965openalex-snapshot
Mitochondrial DNA from hepatocytes as a ligand for TLR9: Drivers of nonalcoholic steatohepatitis?
inferredcites →https://doi.org/10.5152/tjg.2023.22239openalex-snapshot
Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives
inferredcites →https://doi.org/10.5223/pghn.2024.27.4.224openalex-snapshot
Combined Predictors of Long-Term Outcomes of Kasai Surgery in Infants with Biliary Atresia
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.